Kiaran Kirk (Australian National University)

The event will start on: Mon, Jun 18, 2012 | 11:00 am
Location: Carl Icahn Lab, 101 | Washington Road

Lewis Sigler Institute Special Seminar

Speaker
 

kiaran kirk

Kiaran Kirk
research school of biology
Australian national university
 

Kiaran Kirk carried out his PhD in the Department of Biochemistry at the University of Sydney (1985-1988). In 1989 he went to the Oxford University Laboratory of Physiology where he held an Oxford Nuffield Medical Fellowship, the Staines Medical Research Fellowship (Exeter College) and a Lister Institute Senior Research Fellowship. He returned to Australia in 1996 to head the Division of Biochemistry and Molecular Biology in the ANU Faculty of Science, holding this post until taking up his present position as Director of the ANU Research School of Biology in June 2009.

 
 
Seminar Topic

Ion regulation in the malaria parasite:  the target of a new generation of antimalarials

The intraerythrocytic malaria parasite maintains a tight control over its internal ion composition.  In particular, it maintains an intracellular Na+ concentration some ten-fold less than that in its host cell, extruding Na+ via a Na+-ATPase on its plasma membrane.  Bioinformatic analysis of the genome of the human malaria parasite Plasmodium falciparum reveals that the most likely candidate for the parasite’s Na+ ATPase is a protein known as PfATP4.  A recent ‘whole cell’ screen of a large compound library for the ability to inhibit the in vitro growth of P. falciparum, has led to the discovery of a group of highly active antimalarial compounds, the spiroindolones (Rottmann et al. (2010) Science 329, 1175-1180), one of which is now in Phase IIa clinical trials.  Prolonged exposure of P. falciparum parasites to sub-lethal concentrations of spiroindolones leads to the emergence of spiroindolone-resistant parasites, with the resistance attributable to mutations in PfATP4.  For two other (structurally unrelated) candidate antimalarial drug classes, exposure of parasites to sub-lethal concentrations gives rise to resistant parasites that once again have mutations in PfATP4.  In this talk I will introduce the cell physiology of the intracellular malaria parasite and present evidence for the hypothesis that the three compound classes – all of which form part of the Medicines for Malaria Venture’s drug development portfolio – exert their antimalarial effect by inhibiting Na+ extrusion via PfATP4, and thereby disrupting parasite Na+ regulation.

 

research lab

Kirk Lab - Malaria parasite biology

Audience

Free and open to the university community and the public

Hosted by: Manuel Llinas, Lewis Sigler Institute

MolBio Events

Mon, Nov 03, 2014

Wed, Nov 05, 2014

Thu, Nov 06, 2014

Mon, Nov 10, 2014

Contact Us

Lewis Thomas Laboratory at Princeton University

119 Lewis Thomas Laboratory
Washington Road, Princeton, NJ  08544-1014

Need help? Contact us

Fax: (609) 258-3980
Website:  molbio.princeton.edu